{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:03:21Z","timestamp":1790183001152,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-03979-x","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T17:01:50Z","timestamp":1686934910000},"page":"3174-3182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the diagnostic performance of biparametric and multiparametric MRI in detecting muscle invasion of bladder cancer located at the ureteral orifice"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-621X","authenticated-orcid":false,"given":"Uluhan","family":"Eryuruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-8135","authenticated-orcid":false,"given":"Merve Nur","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-7493","authenticated-orcid":false,"given":"Serdar","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"3979_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","DOI":"10.3322\/caac.21492"},{"key":"3979_CR2","doi-asserted-by":"publisher","unstructured":"Soukup V, \u010capoun O, Cohen D, et al. (2017) Prognostic performance and reproducibility of the 1973 and 2004\/2016 World Health Organization grading classification systems in non\u2013muscle-invasive bladder cancer: A European Association of Urology Non-muscle invasive bladder cancer guidelines panel systematic review. European Urology 72:801\u2013813. https:\/\/doi.org\/10.1016\/j.eururo.2017.04.015","DOI":"10.1016\/j.eururo.2017.04.015"},{"key":"3979_CR3","doi-asserted-by":"publisher","unstructured":"Linton KD, Rosario DJ, Thomas F, et al. (2013) Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance.\u00a0The Journal of urology 189:828\u2013833. https:\/\/doi.org\/10.1016\/j.juro.2012.09.084.","DOI":"10.1016\/j.juro.2012.09.084"},{"key":"3979_CR4","doi-asserted-by":"publisher","unstructured":"Josephson D, Pasin E, Stein JP. (2007) Superficial bladder cancer: part 2. Management.\u00a0Expert review of anticancer therapy 7:567\u2013581. https:\/\/doi.org\/10.1586\/14737140.7.4.567.","DOI":"10.1586\/14737140.7.4.567"},{"key":"3979_CR5","doi-asserted-by":"publisher","unstructured":"Witjes JA, Comperat E, Cowan NC, et al. (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65:778\u2013792. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.046.","DOI":"10.1016\/j.eururo.2013.11.046"},{"key":"3979_CR6","doi-asserted-by":"publisher","unstructured":"Kulkarni GS, Hakenberg OW, Gschwend JE, et al. (2010) An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57(1):60\u201370. https:\/\/doi.org\/10.1016\/j.eururo.2009.08.024.","DOI":"10.1016\/j.eururo.2009.08.024"},{"key":"3979_CR7","doi-asserted-by":"publisher","unstructured":"Babjuk M, Bohle A, Burger M, et al. (2017) EAU guidelines on nonmuscle- invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041.","DOI":"10.1016\/j.eururo.2016.05.041"},{"key":"3979_CR8","doi-asserted-by":"publisher","unstructured":"van der Pol CB, Sahni VA, Eberhardt SC, et al. (2018). ACR Appropriateness Criteria \u00ae Pretreatment Staging of Muscle-Invasive Bladder Cancer. J Am Coll Radiol 15(5S):150\u2013159. https:\/\/doi.org\/10.1016\/j.jacr.2018.03.020.","DOI":"10.1016\/j.jacr.2018.03.020"},{"key":"3979_CR9","doi-asserted-by":"publisher","unstructured":"Caglic I, Panebianco V, Vargas HA, et al. (2020) MRI of Bladder Cancer: Local and Nodal Staging. J Magn Reson Imaging 52(3):649-667. https:\/\/doi.org\/10.1002\/jmri.27090.","DOI":"10.1002\/jmri.27090"},{"key":"3979_CR10","doi-asserted-by":"publisher","unstructured":"Panebianco V, Narumi Y, Altun E, et al. (2018) Multiparametric magnetic resonance imaging for bladder Cancer: development of VI-RADS (Vesical imaging-reporting and data system). Eur Urol 74(3):294\u2013306. https:\/\/doi.org\/10.1016\/j.eururo.2018.04.029.","DOI":"10.1016\/j.eururo.2018.04.029"},{"key":"3979_CR11","doi-asserted-by":"publisher","unstructured":"Delli Pizzi A, Mastrodicasa D, Marchioni M, et al. (2021) Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. Eur Radiol. 31(6):3874-3883. https:\/\/doi.org\/10.1007\/s00330-020-07473-6.","DOI":"10.1007\/s00330-020-07473-6"},{"key":"3979_CR12","doi-asserted-by":"publisher","unstructured":"Aslan S, Cakir IM, Oguz U, et al. (2022) Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?.\u00a0Abdominal radiology (New York) 47(2):771\u2013780. https:\/\/doi.org\/10.1007\/s00261-021-03383-3.","DOI":"10.1007\/s00261-021-03383-3"},{"key":"3979_CR13","doi-asserted-by":"publisher","unstructured":"Wang H, Luo C, Zhang F, et al. (2019) Multiparametric MRI for bladder Cancer: validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 291(3):668\u2013674. https:\/\/doi.org\/10.1148\/radiol.2019182506.","DOI":"10.1148\/radiol.2019182506"},{"key":"3979_CR14","doi-asserted-by":"publisher","unstructured":"Ueno Y, Tamada T, Takeuchi M, et al. (2021) VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study. Am J Roentgenol. 216(5):1257-1266. https:\/\/doi.org\/10.2214\/AJR.20.23604.","DOI":"10.2214\/AJR.20.23604"},{"key":"3979_CR15","doi-asserted-by":"publisher","unstructured":"Metwally MI, Zeed NA., Hamed EM, et al. (2021) The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study.\u00a0European radiology 31(9):6949\u20136961. https:\/\/doi.org\/10.1007\/s00330-021-07765-5.","DOI":"10.1007\/s00330-021-07765-5"},{"key":"3979_CR16","doi-asserted-by":"publisher","unstructured":"Cai Q, Ling J, Kong L, et al. (2022) Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.\u00a0Radiology,\u00a0304(3):593\u2013599. https:\/\/doi.org\/10.1148\/radiol.220028.","DOI":"10.1148\/radiol.220028"},{"key":"3979_CR17","doi-asserted-by":"publisher","unstructured":"Kbirou A, Hagguir H, Moataz A, et al. (2022) Acute renal failure and bladder tumors, about 106 cases.\u00a0Nephrologie & therapeutique 18(3):202\u2013206. https:\/\/doi.org\/10.1016\/j.nephro.2021.10.005.","DOI":"10.1016\/j.nephro.2021.10.005"},{"key":"3979_CR18","doi-asserted-by":"publisher","unstructured":"Campbell GA, Hu D, Okusa MD. (2014) Acute kidney injury in the cancer patient.\u00a0Advances in chronic kidney disease 21(1):64\u201371. https:\/\/doi.org\/10.1053\/j.ackd.2013.08.002.","DOI":"10.1053\/j.ackd.2013.08.002"},{"key":"3979_CR19","doi-asserted-by":"publisher","unstructured":"Pecoraro M, Takeuchi M, Vargas HA, et al. (2020) Overview of VI-RADS in Bladder Cancer.\u00a0AJR. American journal of roentgenology 214(6):1259\u20131268. https:\/\/doi.org\/10.2214\/AJR.20.22763.","DOI":"10.2214\/AJR.20.22763"},{"key":"3979_CR20","doi-asserted-by":"publisher","unstructured":"Stephenson WT, Holmes FF, Noble MJ, Gerald KB. (1990) Analysis of bladder carcinoma by subsite Cystoscopic location may have prognostic value.\u00a0Cancer 66(7):1630\u20131635. https:\/\/doi.org\/10.1002\/1097-0142(19901001)66:7<1630::aid-cncr2820660730>3.0.co;2-7.","DOI":"10.1002\/1097-0142(19901001)66:7<1630::aid-cncr2820660730>3.0.co;2-7"},{"key":"3979_CR21","doi-asserted-by":"publisher","unstructured":"Wong-You-Cheong JJ, Woodward PJ, Manning MA, Davis CJ (2006) From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation.\u00a0Radiographics : a review publication of the Radiological Society of North America, Inc 26(6):1847\u20131868. https:\/\/doi.org\/10.1148\/rg.266065126.","DOI":"10.1148\/rg.266065126"},{"key":"3979_CR22","doi-asserted-by":"publisher","unstructured":"Fujii Y, Fukui I, Kihara K, et al. (1998) Significance of bladder neck involvement on progression in superficial bladder cancer.\u00a0European urology 33(5):464\u2013468. https:\/\/doi.org\/10.1159\/000019636.","DOI":"10.1159\/000019636"},{"key":"3979_CR23","doi-asserted-by":"publisher","unstructured":"Woo S, Suh CH, Kim SY, et al. (2017) Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: a systematic review and meta-analysis. Eur J Radiol 95:46\u201355. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.021.","DOI":"10.1016\/j.ejrad.2017.07.021"},{"key":"3979_CR24","doi-asserted-by":"publisher","unstructured":"Arita Y, Shigeta K, Akita H, et al. (2020) Clinical utility of the Vesical imaging-reporting and data system for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions. Eur Radiol 31: 875-883. https:\/\/doi.org\/10.1007\/s00330-020-07153-5.","DOI":"10.1007\/s00330-020-07153-5"},{"key":"3979_CR25","doi-asserted-by":"publisher","unstructured":"Hong SB, Lee NK, Kim S, et al. (2020) Vesical imaging-reporting and data system for multiparametric MRI to predict the presence of muscle invasion for bladder Cancer. J Magn Reson Imaging 52(4):1249\u20131256. https:\/\/doi.org\/10.1002\/jmri.27141.","DOI":"10.1002\/jmri.27141"},{"key":"3979_CR26","doi-asserted-by":"publisher","unstructured":"van der Pol CB, Chung A, Lim C, et al. (2018) Update on multiparametric MRI of urinary bladder cancer. J Magn Reson Imaging 48:882\u2013896. https:\/\/doi.org\/10.1002\/jmri.26294.","DOI":"10.1002\/jmri.26294"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-03979-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T20:40:17Z","timestamp":1693946417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-03979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["3979"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-03979-x","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Due to its retrospective design, we waived the requirement for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This retrospective study was approved by Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to its retrospective design, we waived the requirement for informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}